Dr. Max Kates, MD

NPI: 1487910600
Total Payments
$62,350
2024 Payments
$24,287
Companies
15
Transactions
56
Medicare Patients
3,192
Medicare Billing
$541,373

Payment Breakdown by Category

Consulting$51,815 (83.1%)
Other$7,000 (11.2%)
Travel$2,255 (3.6%)
Food & Beverage$1,280 (2.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $51,815 26 83.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,000 2 11.2%
Travel and Lodging $2,255 12 3.6%
Food and Beverage $1,280 16 2.1%

Top Paying Companies

Company Total Records Latest Year
UROGEN PHARMA, INC. $17,315 9 $0 (2024)
Photocure Inc $14,131 8 $0 (2023)
Merck Sharp & Dohme LLC $7,838 8 $0 (2024)
Astellas Pharma Global Development $5,900 3 $0 (2024)
Seagen Inc. $4,550 3 $0 (2023)
Intuitive Surgical, Inc. $4,007 12 $0 (2020)
PFIZER INC. $3,747 3 $0 (2024)
E.R. Squibb & Sons, L.L.C. $1,950 1 $0 (2022)
Janssen Global Services, LLC $1,550 1 $0 (2020)
Olympus Winter & Ibe GmbH $1,080 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $24,287 18 UROGEN PHARMA, INC. ($17,264)
2023 $10,443 5 Photocure Inc ($4,500)
2022 $20,249 15 Photocure Inc ($9,375)
2021 $1,500 1 Seagen Inc. ($1,500)
2020 $1,635 2 Janssen Global Services, LLC ($1,550)
2019 $3,922 11 Intuitive Surgical, Inc. ($3,922)
2018 $314.41 4 Photocure Inc ($256.12)

All Payment Transactions

56 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
12/17/2024 UROGEN PHARMA, INC. Consulting Fee Cash or cash equivalent $10,000.00 General
11/22/2024 UROGEN PHARMA, INC. Consulting Fee Cash or cash equivalent $2,000.00 General
11/12/2024 PFIZER INC. PADCEV (Biological) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: Oncology
10/02/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $18.83 General
Category: ONCOLOGY
09/11/2024 Ethicon US, LLC Echelon Flex (Device) Food and Beverage In-kind items and services $36.74 General
Category: Endo-Mechanical
06/13/2024 UROGEN PHARMA, INC. Consulting Fee Cash or cash equivalent $4,000.00 General
06/13/2024 UROGEN PHARMA, INC. Travel and Lodging Cash or cash equivalent $573.51 General
06/13/2024 UROGEN PHARMA, INC. Travel and Lodging In-kind items and services $500.00 General
06/13/2024 UROGEN PHARMA, INC. Food and Beverage In-kind items and services $151.34 General
06/13/2024 UROGEN PHARMA, INC. Travel and Lodging Cash or cash equivalent $24.00 General
06/12/2024 UROGEN PHARMA, INC. Travel and Lodging Cash or cash equivalent $15.00 General
06/05/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $545.00 General
05/22/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $588.60 General
04/30/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $28.05 General
Category: ONCOLOGY
04/09/2024 Olympus Winter & Ibe GmbH Single Use Repositionable Clip (Device) Consulting Fee Cash or cash equivalent $1,080.00 General
Category: Endotherapy
03/22/2024 Astellas Pharma Global Development Padcev (Drug) Consulting Fee Cash or cash equivalent $1,400.00 General
Category: Oncology
03/04/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $545.00 General
02/19/2024 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $681.25 General
12/04/2023 Astellas Pharma Global Development Padcev (Drug) Consulting Fee Cash or cash equivalent $2,100.00 General
Category: Oncology
11/29/2023 Merck Sharp & Dohme LLC Consulting Fee Cash or cash equivalent $817.50 General
08/02/2023 Photocure Inc CYSVIEW (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,500.00 General
Category: ONCOLOGY
03/24/2023 Seagen Inc. PADCEV (Biological) Consulting Fee Cash or cash equivalent $1,525.00 General
Category: Oncology
01/13/2023 PFIZER INC. Consulting Fee Cash or cash equivalent $1,500.00 General
12/19/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $1,950.00 General
12/14/2022 Photocure Inc CYSVIEW (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 952 1,203 $1.3M $189,354
2022 15 898 1,177 $1.2M $173,816
2021 15 795 962 $807,618 $111,996
2020 12 547 618 $551,484 $66,206
Total Patients
3,192
Total Services
3,960
Medicare Billing
$541,373
Procedure Codes
63

All Medicare Procedures & Services

63 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
51595 Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening Facility 2023 16 16 $147,184 $29,656 20.1%
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope Facility 2023 32 32 $176,640 $23,404 13.2%
50820 Connection of ureter to small bowel with creation of opening from ureter to skin Facility 2023 17 17 $96,524 $20,711 21.5%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2023 213 317 $197,816 $19,458 9.8%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 121 121 $60,500 $17,580 29.1%
51999 Other procedure on bladder using an endoscope Facility 2023 18 18 $98,611 $16,723 17.0%
52235 Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm Facility 2023 57 64 $130,624 $15,397 11.8%
52240 Destruction and/or removal of large growth of bladder using an endoscope Facility 2023 36 38 $121,828 $12,466 10.2%
52234 Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm Facility 2023 45 52 $76,804 $10,070 13.1%
38571 Removal of lymph nodes of both sides of pelvis using an endoscope Facility 2023 28 28 $112,028 $7,801 7.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 106 137 $26,851 $7,470 27.8%
51700 Simple bladder irrigation and/or instillation Facility 2023 187 287 $71,873 $3,413 4.7%
55700 Biopsy of prostate gland Facility 2023 13 13 $8,944 $1,297 14.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 16 16 $4,882 $1,240 25.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 12 12 $3,804 $1,161 30.5%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 13 13 $4,121 $788.84 19.1%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Facility 2023 11 11 $2,245 $449.10 20.0%
76872 Ultrasound scan of pelvic region through rectum Facility 2023 11 11 $3,201 $270.20 8.4%
55866 Surgical removal of prostate and surrounding lymph nodes using an endoscope Facility 2022 32 32 $179,400 $30,882 17.2%
51595 Removal of bladder and lymph nodes on both sides of pelvis with transplantation of ureters to small or large bowel with creation of urinary opening Facility 2022 14 14 $133,386 $26,430 19.8%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2022 241 378 $226,800 $24,108 10.6%
51999 Other procedure on bladder using an endoscope Facility 2022 15 15 $84,250 $14,986 17.8%
50820 Connection of ureter to small bowel with creation of opening from ureter to skin Facility 2022 13 13 $59,755 $14,137 23.7%
52235 Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm Facility 2022 53 55 $112,255 $12,867 11.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 65 65 $32,500 $10,017 30.8%

About Dr. Max Kates, MD

Dr. Max Kates, MD is a Surgery healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1487910600.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Max Kates, MD has received a total of $62,350 in payments from pharmaceutical and medical device companies, with $24,287 received in 2024. These payments were reported across 56 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($51,815).

As a Medicare-enrolled provider, Kates has provided services to 3,192 Medicare beneficiaries, totaling 3,960 services with total Medicare billing of $541,373. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.

Practice Information

  • Specialty Surgery
  • Other Specialties Urology
  • Location Baltimore, MD
  • Active Since 04/03/2012
  • Last Updated 08/02/2012
  • Taxonomy Code 208600000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1487910600

Products in Payments

  • CYSVIEW (Drug) $13,875
  • PADCEV (Biological) $6,650
  • Padcev (Drug) $5,900
  • Da Vinci Surgical System (Device) $4,007
  • Single Use Repositionable Clip (Device) $1,080
  • Cysview (Drug) $256.12
  • Echelon Flex (Device) $36.74
  • LoFric (Device) $36.07
  • KEYTRUDA (Biological) $28.05
  • GREENLIGHT (Device) $22.22
  • ADSTILADRIN (Biological) $18.83
  • iTIND System (Device) $18.73

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Surgery Doctors in Baltimore